advertisement
11.15 Other drugs in relation to glaucoma (64)
Showing records 1 to 25
Display all abstracts in classification 11.15 Other drugs in relation to glaucoma
Search within classification 11.15 Other drugs in relation to glaucoma71466 Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent
Faiq MA
Current Molecular Medicine 2017; 0:
71556 Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension
Kaufman PL
Expert Opinion in Pharmacotherapy 2017; 18: 433-444
71332 Association of Daily Dosage and Type of Statin Agent With Risk of Open-Angle Glaucoma
Talwar N
JAMA ophthalmology 2017; 135: 263-267
71355 Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration
Saleh R
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 817-824
71019 Randomized Prospective Study of the Use of Anti-Inflammatory Drops After Selective Laser Trabeculoplasty
De Keyser M
Journal of Glaucoma 2017; 26: e22-e29
71629 Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
Chen VC
PLoS ONE 2017; 12: e0173005
71444 Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits
Panchal SS
Journal of Ophthalmology 2017; 2017: 1468716
71061 Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
Inazaki H
Journal of Glaucoma 2017; 26: 96-100
71448 Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol
Kola M
International Ophthalmology 2018; 38: 385-388
71614 Bilateral ciliary body oedema under treatment with ciclosporine
Braun R
Ophthalmologe 2018; 115: 55-58
71224 Rho kinase inhibitors: a patent review (2014 - 2016)
Defert O
Expert Opinion on Therapeutic Patents 2017; 0: 1-9
71550 Can Anti-VEGF Injections Cause Glaucoma or Ocular Hypertension?
Lanzl I
Klinische Monatsblätter für Augenheilkunde 2017; 234: 191-193
71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Ho H
JAMA ophthalmology 2017; 135: 196-202
71553 Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty
Zhang L
Cochrane Database of Systematic Reviews 2017; 2: CD010746
71334 Impact of Drugs on Glaucoma and Intraocular Pressure
Schlote T
Klinische Monatsblätter für Augenheilkunde 2017; 234: 179-184
71239 Efficacy and safety of adding ripasudil to existing treatment regimens for reducing intraocular pressure
Inoue K
International Ophthalmology 2018; 38: 93-98
71355 Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration
Karpe A
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 817-824
71239 Efficacy and safety of adding ripasudil to existing treatment regimens for reducing intraocular pressure
Okayama R
International Ophthalmology 2018; 38: 93-98
71629 Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
Ng MH
PLoS ONE 2017; 12: e0173005
71444 Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits
Patidar RK
Journal of Ophthalmology 2017; 2017: 1468716
71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Shi Y
JAMA ophthalmology 2017; 135: 196-202
71448 Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol
Hacıoğlu D
International Ophthalmology 2018; 38: 385-388
71614 Bilateral ciliary body oedema under treatment with ciclosporine
Holler E
Ophthalmologe 2018; 115: 55-58
71224 Rho kinase inhibitors: a patent review (2014 - 2016)
Boland S
Expert Opinion on Therapeutic Patents 2017; 0: 1-9
71466 Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent
Dada T
Current Molecular Medicine 2017; 0:
